Tower Research Capital (TRC)’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6K | Buy |
8,197
+1,274
| +18% | +$4.75K | ﹤0.01% | 3384 |
|
|
2025
Q1 | $19.1K | Buy |
6,923
+3,512
| +103% | +$9.69K | ﹤0.01% | 3016 |
|
|
2024
Q4 | $18.9K | Sell |
3,411
-2,706
| -44% | -$15K | ﹤0.01% | 3229 |
|
|
2024
Q3 | $51K | Sell |
6,117
-2,608
| -30% | -$21.8K | ﹤0.01% | 2709 |
|
|
2024
Q2 | $59.4K | Buy |
8,725
+8,106
| +1,310% | +$55.2K | ﹤0.01% | 2963 |
|
|
2024
Q1 | $4.06K | Sell |
619
-22,377
| -97% | -$147K | ﹤0.01% | 4745 |
|
|
2023
Q4 | $149K | Buy |
22,996
+21,942
| +2,082% | +$142K | ﹤0.01% | 2322 |
|
|
2023
Q3 | $5.3K | Sell |
1,054
-6,957
| -87% | -$35K | ﹤0.01% | 4738 |
|
|
2023
Q2 | $70.1K | Buy |
8,011
+4,361
| +119% | +$38.2K | ﹤0.01% | 2288 |
|
|
2023
Q1 | $43K | Sell |
3,650
-1,889
| -34% | -$22.3K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $57K | Sell |
5,539
-1,062
| -16% | -$10.9K | ﹤0.01% | 2260 |
|
|
2022
Q3 | $39K | Sell |
6,601
-3,879
| -37% | -$22.9K | ﹤0.01% | 3387 |
|
|
2022
Q2 | $26K | Buy |
10,480
+6,924
| +195% | +$17.2K | ﹤0.01% | 3521 |
|
|
2022
Q1 | $11K | Buy |
3,556
+2,013
| +130% | +$6.23K | ﹤0.01% | 4216 |
|
|
2021
Q4 | $11K | Buy |
1,543
+784
| +103% | +$5.59K | ﹤0.01% | 4457 |
|
|
2021
Q3 | $8K | Sell |
759
-421
| -36% | -$4.44K | ﹤0.01% | 4569 |
|
|
2021
Q2 | $14K | Buy |
1,180
+566
| +92% | +$6.72K | ﹤0.01% | 4190 |
|
|
2021
Q1 | $14K | Buy |
+614
| New | +$14K | ﹤0.01% | 4168 |
|